Prostate Cancer - Results from #20

Contemporary neighborhood redlining and racial mortgage lending bias and disparities in prostate cancer survival. April 17, 2025

Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer. April 17, 2025

National Cancer System Characteristics and Prostate Cancer Outcomes: An Analysis of Global Data. April 17, 2025

Lessons from the implementation of the Australian 2016 prostate specific antigen testing clinical practice guidelines: a descriptive study. April 17, 2025

Prostate Cancer Screening Among Traditionally Underserved Populations at a Large Public Safety-Net Institution. April 17, 2025

Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting (2) April 16, 2025

Clinical Outcomes and Genomic Alterations in Gleason Score 10 Prostate Cancer. April 16, 2025

Analytical Validation of MyProstateScore 2.0. April 16, 2025

Adverse In-Hospital Outcomes Following Robot-Assisted vs. Open Radical Prostatectomy in Quadragenarians. April 16, 2025

Single-Dose Radiation Therapy for Localized Prostate Cancer: Where Does the Evidence Lead? April 16, 2025

Developing a Predictive Model for Significant Prostate Cancer Detection in Prostatic Biopsies from Seven Clinical Variables: Is Machine Learning Superior to Logistic Regression? April 16, 2025

SECuRE Trial Update: First Patient Treated in the Phase II Cohort Expansion April 15, 2025

Predictors of bladder spasm during catheter-indwelling in discharged patients after robot-assisted laparoscopic radical prostatectomy. April 15, 2025

Do differences in secondary treatment explain mortality impact of prostate cancer screening? - A randomized screening trial. April 15, 2025

Long-term Oncological Outcomes of Partial Gland Cryoablation of Localized Prostate Cancer with Median Follow-up of 7 Years: A Single-institution Experience. April 15, 2025

Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment. April 15, 2025

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants. April 15, 2025

An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled Trial. April 15, 2025

External Validation of an Artificial Intelligence Algorithm Using Biparametric MRI and Its Simulated Integration with Conventional PI-RADS for Prostate Cancer Detection. April 15, 2025

Visceral metastases, platelet dynamics, and PSA decline: from biomarkers to better outcomes in [177Lu]Lu‑PSMA‑617 therapy in metastatic castration-resistant prostate cancer. April 14, 2025

Page 2 of 1473